Biond Biologics

Immunotherapies for Cancer and Auto-immune Diseases

Startup

Biond Biologics is a startup in the Health Tech & Life Sciences sector, established in 2016. Immunotherapies for Cancer and Auto-immune Diseases. The company has raised a total of $37M across 3 funding rounds, currently at the C stage. Biond Biologics was founded by Tehila Ben Moshe and Ori Shilo. Key investors include Deep Insight, Heritage Group, Harel Insurance & Finance, among 6 total investors. The company has 11-50 employees. Core technologies: Biologicals, Cells.

With $37M in total funding, Biond Biologics is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.

$37M
Raised
3
Rounds
6
Investors
8
Team
2016
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsCells
At a Glance
Investors

6 investors total

Founders
In the News

9 articles covered by sources including www.prnewswire.com, www.globenewswire.com, en.globes.co.il.

www.prnewswire.com · Oct 8, 2025
/PRNewswire/ -- Biond Biologics Ltd. ("Biond" or the "Company"), a private, clinical-stage biopharmaceutical company developing novel immunotherapies for...
Read article ↗
Frequently Asked Questions
What does Biond Biologics do?

Biond Biologics is a biotechnology company developing immunotherapies and an intracellular drug delivery platform for the treatment of cancer patients. The company uses biologics targeting novel immune evasion mechanisms, discovered through in-house research utilizing real-world patient and tumor samples. Biond Biologics is developing an intracellular delivery platform for biologics (e.g., antibodies or enzymes) inside cells, allowing the company to drug intracellular targets currently considered "undruggable."

How much funding has Biond Biologics raised?

Biond Biologics has raised $37M in total funding across 3 rounds. The company is currently at the C stage. Key investors include Deep Insight, Heritage Group, Harel Insurance & Finance.

Who founded Biond Biologics?

Biond Biologics was founded in 2016 by Tehila Ben Moshe (Co-founder, Chairperson & CEO), Ori Shilo (Co-founder & CFO).

What sector is Biond Biologics in?

Biond Biologics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is Biond Biologics located?

Biond Biologics is based in Misgav, Israel.

View Full Profile Classic View Website ↗